FDA applicant
Nxstage Medical, Inc.
FDA records 51 decisions for Nxstage Medical, Inc. (Lawrence, MA) from 2001 to 2024: 51 510(k) clearances. Most are in product codes KDI (Dialyzer, High Permeability With Or Without…) and KPO (Dialysate Concentrate For Hemodialysis (Liquid…). Since 2016 its 510(k)s took a median of 135 days from receipt to decision, against 188 for FDA’s reviews in the same codes and years. Its devices cite 75 predicates, 40 of them its own earlier devices. 51 recalls are linked to its devices, 7 Class I.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Nxstage Medical, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2024
2026 so far, outlined.
Recalls per year
6in 2026
Class I Class II/III not classified
Planning a device like Nxstage Medical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report